Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Repligen Sweden AB
AB
Active
Org 5568690704
Sankt Lars Väg 47, 222 70
Lund
Manufacture of basic pharmaceutical products
·
NACE 2110
Est. 2011 · 14 years old
100-199 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of basic pharmaceutical products
/
Repligen Sweden AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
TM
Torbjörn Mikael Åberg
Chief Auditor
Chief Auditor
2021
PA
Per Anders Hestner
External Signatory
External Signatory
2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
CM
Christian Magnus Pedersen
Board of Directors
Board of Directors
2021
LG
Lars Gustav Silfversparre
Board of Directors
Board of Directors
2025
JR
James Richard Bylund
Chairman
Chairman
2025
PK
Patrick Kennedy Martin
Board of Directors
Board of Directors
2021
Former (3)
LO
Lars Ola Martin Olsson Modig
Board of Directors
Board of Directors
2023 – 2023
AH
Anthony Hunt
Chairman
Chairman
2021 – 2025
JS
Jon Snodgres
Board of Directors
Board of Directors
2023 – 2024
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
REPLIGEN CORPORATION
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Repligen Sweden AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
